SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Kaleido Biosciences Q1 EPS $(0.640), Inline

Kaleido Biosciences (NASDAQ:KLDO) reported quarterly losses of $(0.640) per share which met the analyst consensus estimate. This is a 58.97 percent increase over losses of $(1.560) per share from the same period last

Benzinga · 05/14/2020 10:35

Kaleido Biosciences (NASDAQ:KLDO) reported quarterly losses of $(0.640) per share which met the analyst consensus estimate. This is a 58.97 percent increase over losses of $(1.560) per share from the same period last year.